General form of registration statement for all companies including face-amount certificate companies

Fair Value Measurements

v3.21.2
Fair Value Measurements
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Fair Value Disclosures [Abstract]    
Fair Value Measurements

4. Fair Value Measurements

Fair Value of Financial Instruments

The carrying amounts of cash, restricted cash, accounts receivable, prepaid expenses, accounts payable, and customer deposits approximate fair value due to their short-term nature. As of June 30, 2021, the fair value of the Company’s loan payable and the PPP Loan was $16.1 million and $2.0 million, respectively. As of June 30, 2021, the carrying value of the Company loan payable and the PPP Loan was $14.5 million and $2.2 million, respectively. The estimated fair value for the Company’s loan payable and PPP Loan was based on discounted expected future cash flows using prevailing interest rates which are Level 3 inputs under the fair value hierarchy.

4. Fair Value Measurements

The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis:

 

December 31, 2020

   

(Level 1)

 

(Level 2)

 

(Level 3)

Liabilities

 

 

   

 

   

 

 

Preferred stock warrant liability

 

$

 

$

 

$

 

December 31, 2019

   

(Level 1)

 

(Level 2)

 

(Level 3)

Liabilities

 

 

   

 

   

 

 

Preferred stock warrant liability

 

$

 

$

 

$

4,391,372

The Company’s Series B preferred stock warrants were classified as liabilities, recorded at fair value and subject to re-measurement at each balance sheet date until they were converted into common stock warrants in connection with the completion of the Merger. The common stock warrants are equity classified as of the Merger date and are no longer subject to remeasurement.

The Series B preferred stock warrant liabilities are estimated using an option pricing model. The significant assumptions used in valuing the warrants include expected term, expected volatility, risk-free interest rate and expected dividend yield. As of Merger date, immediately prior to reclassifying the warrants to equity, and as of December 31, 2019 the significant weighted-average assumptions were as follows:

 

October 5,

 

December 31,

   

2020

 

2019

Risk-free interest rate

 

 

0.7

%

 

 

1.9

%

Remaining contractual life of warrant (years)

 

 

8.9

 

 

 

9.7

 

Expected volatility

 

 

57.8

%

 

 

50.9

%

Annual dividend yield

 

 

0

%

 

 

0

%

Fair value of Series B convertible preferred stock

 

$

1.26

 

 

$

1.14

 

The reconciliation of the Series B preferred stock warrant liability measured at fair value, until the reclassification into equity at the time of the Merger, on a recurring basis using significant unobservable inputs (Level 3) was as follows:

Balance, January 1, 2019

 

$

328,559

 

Issuance of warrants in connection with Series B financing

 

 

3,991,178

 

Change in fair value recorded as other expense

 

 

71,635

 

Balance, December 31, 2019

 

 

4,391,372

 

Issuance of warrants in connection with Series B financing

 

 

95,478

 

Change in fair value recorded as other expense

 

 

743,837

 

Reclassification to equity

 

 

(5,230,687

)

Balance, December 31, 2020

 

$

 

Fair Value of Financial Instruments

The carrying amounts of cash, restricted cash, accounts receivable, prepaid expenses, accounts payable, customer deposits, and note payable approximate fair value due to their short-term nature. As of December 31, 2020, the fair value of the Company’s subordinated note payable and the PPP Loan was $10,600,000 and $1,900,000, respectively. As of December 31, 2020, the carrying value of the Company subordinated note payable and the PPP Loan was $10,072,163 and $2,180,300, respectively. The estimated fair value for the Company’s subordinated note payable and PPP Loan was based on discounted expected future cash flows using prevailing interest rates which are Level 3 inputs under the fair value hierarchy.